Summary of today...Pace of enrollment still sucks
the "market" (actually the sum of all holders of Spectral shares which is a poor proxy for a market) does not appear to be very concerned. (see unchanged SP and low volume)
Eden and Euphas-2 results hinted at are very encouraging (increasing the odds of a favourable & eventual FDA ruling ? and perhaps a richer buyout? )
Baxter appears to be laying some great groundwork (increasing odds of ultimate approval? and an eventual "transaction" ?)
Poor enrolment numbers of late, may have been offset by the good news of improved odds of ultimate approval (see EDEN and Euphas 2) - at least collectively in the minds of the (small) invested population.
"Key Pout" sign at SH still in full vigor...discouraging to a higher SP (mision accomplished?)
Still not buying the "lifestyle" argument. Very lame.
Hopeful that the BIG investors + Baxter are growiing impatient and will apply the requisite amount of pressure...in order to get things ramped up to a better pace in 2023. Need more creativity than adding new sites (with all the training and set-up that goes with that)
the BoD should be well prepared to defend/justify any addional performance bonuses/options that may be granted over the next few months.
Have a great day everyone.
MM